Company: DMAAR
Filing Date: 2025-01-06
Form Type: S-1/A
Source: 0001213900-25-001208
Chunk: 3

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-06
Form: S-1/A
Chunk 3
---
 referred to by an undersigned registrant; (iii)the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv)any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. II-2

SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Amendment No. 6 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fort Lauderdale, State of Florida, on the 6 thday of January, 2025.

| Drugs Made In America Acquisition Corp. |     |                                             |
| By:                                     |     | /s/ Lynn Stockwell                          |
| Name:                                   |     | Lynn Stockwell                              |
| Title:                                  |     | Chief Executive Officer and Executive Chair |

Pursuant to the requirements of the Securities Act of 1933, as amended, this Amendment No. 6 to the Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

| Name               
 /s/ Lynn Stockwell |     | Position                                    
 Chief Executive Officer and                 
 Executive Chair                             |     | Date            
 January 6, 2025 |
|:-------------------|:----|:--------------------------------------------|:----|:----------------|
| Lynn Stockwell     |     | -principal executive officer                |     |                 |
| /s/ Glenn Worman   |     | Chief Financial Officer                     |     | January 6, 2025 |
| Glenn Worman       |     | -principal financial and accounting officer |     |                 |

II-3